Physalin D was isolated from the methanol extract of Physalis alkekengi L. fruits by combination of different chromatographic methods (CPC, TLC, HPLC). The structure was elucidated based on 1 H and 13 C NMR spectral analysis with the aid of 2D-correlation spectroscopy ( 1 H, 1 H-COSY, HSQC and HMBC) and comparison with literature data. The quantity of physalin D in mature and immature fruits and calyces was determined by RP-HPLC-UV method. Among the studied samples, immature calyx showed the highest content of physalin D (0.7880 ± 0.0612%), while mature calyx contained 4 times less amount (0.2028 ± 0.016%). The physalin D content of the fruit was much lower; immature fruits contained 0.0992 ± 0.0083% physalin D and mature fruits 0.0259 ± 0.0021%. The antiproliferative activity of the CHCl 3 extract and its fractions was tested on three cancer cell lines (HeLa, MCF-7 and A431). The antiproliferative activity of physalin D is discussed with regard the published data.
INTRODUCTION
The genus Physalis, which belongs to the family Solanaceae, includes about 120 species, mainly distributed in Mexico, Europe, and Southeast and Central Asia. The fruit of the most widely used plant Ph. alkekengi var. franchetii (Mast) Makino (Chinese lantern) is popular as fruit and food additive, and is also used in the traditional Chinese medicine for the treatment of different diseases [25] . Ph. alkekengi L., known as "winter cherry" grows in western-Asia, Middle-and South-Europe; this is the only species of the genus occurring in the Carpathian-Basin [2, 23] . Previous studies have focused on the antileukemic, antitumor, immunomodulator, antiprotozoal, molluscicidal, antihepatoma, and antinociceptive activities of Physalis species [1] .
Physalis species are known to contain different type of compounds, including physalins, alkaloids, flavonoids, carotenoids, vitamins and polysaccharides, among which physalins are the most active representative of secondary metabolites of the genus. Physalins are steroidal constituents, they possess a 16,24-cyclo-13,14-secoergostan framework, and are classified into types A and B according to the presence or absence of a C(14)-O-C(27) epoxy linkage, respectively ( Fig. 1) [5, 19] .
The first physalins were isolated from Physalis alkekengi var. franchetii (Mast) Makino [10, 13, 20, 21] . A large number of physalins have been characterized in the past years, mostly isolated from roots and aerial part of Physalis species [3, 7, 9, 17, 18, 29, 30, 31] . Some physalins were known to exert cytotoxic activity against tumor cells [3, 8, 19] . Moreover, their antimalarial, antimycobacterial, antileishmanial, antinociceptive and chemopreventive activities were also demonstrated [4, 14, 22, 32] .
and Ph. pubescens L. are the most studied species and more than 30 physalins have been described from these plants [11, 12, 16, 18, 26, 27, 28, 33] . In case of Ph. alkekengi, physalins D, L, N and O were isolated from the herb and calyx [6, 12, 28] , and physalin D was found to be the main constituent. No comprehensive study has yet been reported about the content of this compound in the fruits and calyces, therefore our aim was the isolation and quantitative determination of physalin D. With regard to the cytotoxic activity of physalins, the isolation process was guided by in vitro cytotoxic assay.
MATERIALS AND METHODS

General
1 H-NMR and 13 C-NMR spectra were recorded in DMSO-d 6 and CDCl 3 using TMS as internal standard at 500 and 125 MHz, respectively, on a Bruker Avance DRX500 spectrometer. Centrifugal planar chromatographic (CPC) separation was performed using a Chromatotron ® (Harrison Research Model 8924, USA) apparatus. HPLC separation was performed using a Waters Separation Module with a Waters 600 Controller and Waters 2998 PDA detector on a LiChroCART RP18 column (5 µm, 250 × 4 mm). Operation and data acquisition was performed using Empower Pro Software. All chemicals used for extraction and isolation were of analytical or HPLC- Fig. 1 
Extraction and isolation
A 200 g dried powdered mature fruit without calyx was macerated in 400 mL 50% MeOH overnight, then extracted with 2000 mL 50% MeOH by percolation, and concentrated in vacuum to approximately 400 mL. This extract was separated by solvent-solvent extraction with n-hexane and then with chloroform. The chloroform extract was concentrated under reduced pressure and fractionated using different chromatographic methods. CPC separation of chloroform extract was performed on silica gel 60GF 254 with gradient system of cyclohexane-EtOAc-EtOH-MeOH of increasing polarity gaining 74 fractions. These fractions were monitored by TLC (silica gel 60F 254 , cyclohexaneEtOAc 3:7) and the appropriate fractions were combined in fractions P1 -P7.
Fractions P1 -P7 were tested for antiproliferative activity in order to find active fractions or compounds.
Antiproliferative assay
Antiproliferative effects were measured in vitro on three human cell lines (ECACC; Salisbury, UK): HeLa (cervix adenocarcinoma), MCF-7 (breast adenocarcinoma) and A431 (skin epidermoid carcinoma). The cells were cultivated in minimum essential medium (Gibco BRL; Paisley, UK) supplemented with 10% fetal bovine serum, 1% non-essential amino acids and an antibiotic mixture in a humified atmosphere of 5% CO 2 at 37 °C. Cells were seeded into a 96-well plate at a density of 5000 cells/well. After the plate stood overnight, the medium containing the tested samples was added. Ten mg/mL stock solutions of the tested samples were prepared with dimethyl sulfoxide (DMSO) and the highest DMSO concentration of the medium (0.3%) did not have any significant effect on cell proliferation. After a 72-h incubation period, cytotoxicity was measured with the MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]) assay [23] . After a 4-h contact period, the precipitated formazan crystals were dissolved in DMSO, and the absorbance was read at 545 nm with an ELISA reader. Doxorubicin and cisplatin were used as positive controls; their IC 50 values were 0.15 mM (HeLa), 0.28 mM (MCF-7), 0.15 mM (A431) for doxorubicin, and 12.43 mM (HeLa), 9.63 mM (MCF-7), 2.84 mM (A431) for cisplatin.
Quantitative HPLC determination of physalin D
Column: LiChroCART RP18 (5 µm, 250 × 4 mm), mobile phase: acetonitrile-H 2 O (7:3), flow rate 0.7 mL/min, or acetonitrile-H 2 O (1:1), flow rate 0.4 mL/min; or MeOH-H 2 O (4:6), flow rate 0.7 mL/min, detection at 225.4 nm. Sample preparation: extracts were prepared from 1 g exactly weighted powdered plant materials with 25 mL 50% MeOH by ultrasound assisted extraction for 15 minutes. The extracts were concentrated in vacuum to approximately ½ volumes. These extracts were purified with extraction of n-hexane (5 × 30 mL) in a separation funnel, followed by extraction with chloroform (5 × 30 mL). The chloroform phases were combined, evaporated and before HPLC analysis dissolved in 500 μL MeOH. Injected volume: 10 µL.
RESULTS AND DISCUSSION
Dried and ground fruits without calyces of Ph. alkekengi were extracted with 50% MeOH. After concentration, the extract was subjected to solvent-solvent partition, yielding n-hexane, CHCl 3 and aqueous MeOH fractions. The antiproliferative effect of the CHCl 3 extract was tested on HeLa and MCF-7 cell lines (Table 1) . This extract was fractionated by CPC on silica gel and after TLC monitoring seven fractions (P1 -P7) were obtained.
Antiproliferative effect of fractions P1 -P7 was tested on HeLa, MCF-7 and A431 cell lines. The most active fraction was P3 on all cell lines, followed by P2 and P4 on HeLa and MCF-7 cells, and P4 on the A431 cell line (Table 2) .
A white crystalline substance (1) was isolated from fraction P3 by crystallization from cold MeOH. The structure of compound 1 was elucidated by means of 1 H and 13 C NMR spectral analysis. The 13 C NMR spectrum was recorded in CDCl 3 and in DMSO, and showed a sterol-type molecule with 28 C atoms, suggesting physalin structure. The unambiguous NMR signal assignment was achieved with the aid of Table 3) . Compound 1 was identical in all of its spectral characteristics with physalin D (Fig. 2 ) [7] . Strong cytotoxic activity of this compound was reported by Magalhães et al. 
Quantitative determination of physalin D in fruits and calyces
The quantitative determination of physalin D (1) was achieved by RP-HPLC-UV method with detection at 225.4 nm, the UV absorption maximum of the compound (Fig. 3) . CHCl 3 extracts were prepared from the dried mature and immature fruits and calyces with solvent-solvent partition of the 50% MeOH extract. The first step of the quantitative analysis was the determination of the calibration curve. As shown in Fig. 4 , good linearity was obtained with R 2 > 0.9972. HPLC separation was performed on LiChroCART RP18 reversed phase column with one of the acetonitrile-H 2 O mixtures as mobile phases (see Materials and Methods), depending on the composition of the extract, trying to obtain an efficient separation in the area of interest. A representative chromatogram is presented in Fig. 5 . Among the studied samples, immature calyx showed the highest content of physalin D (1) (0.7880 ± 0.0612 g%), while mature calyx contains 4 times less (0.2028 ± 0.016 g%). The physalin D (1) content of the fruit is much lower; immature fruits contain 0.0992 ± 0.0083 g% physalin D and mature fruits 0.0259 ± 0.0021 g% (Table 4 , Fig. 6 ).
In conclusion, with combination of different chromatographic methods physalin D (1) was isolated from the 50% MeOH extract of Ph. alkekengi fruits. The structure was elucidated by 1 H and 13 C NMR spectral analysis with the aid of 2D-correlation spectroscopy ( 1 H, 1 H-COSY, HSQC and HMBC) and comparison with literature data. The quantity of physalin D (1) was evaluated in fruits and calyces and cytotoxic activity was tested on three cancer cell lines (HeLa, MCF-7 and A431). The occurrence and quantitative determination of physalin D in fruits of Ph. alkekengi is reported here for the first time.
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